Articles From: IIROC Trade Resumption - SVB to Keryx Biopharmaceuticals Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors


2013/2/6
IIROC Trade Resumption - SVB Canada NewsWire TORONTO , Feb.
Sign-up for IIROC Trade Resumption - SVB investment picks
2013/2/6
IIROC Trading Halt - INN.UN Canada NewsWire TORONTO , Feb.
Sign-up for IIROC Trading Halt - INN.UN investment picks
2013/2/6
IIROC Trading Halt - SMA (all issues) Canada NewsWire TORONTO , Feb.
Sign-up for IIROC Trading Halt - SMA (all issues) investment picks
2013/2/6
IIROC Trading Halt - SVB Canada NewsWire TORONTO , Feb.
Sign-up for IIROC Trading Halt - SVB investment picks
2013/2/6
IIROC Trading Halt - SW (all issues) Canada NewsWire TORONTO , Feb.
Sign-up for IIROC Trading Halt - SW (all issues) investment picks
2013/2/6
Rand Worldwide (OTCBB: RWWI) , a global leader in providing technology solutions to organizations with engineering design and information technology requirements, today announced the IMAGINiT Technologies division has received national authorization from Autodesk to serve the design engineering needs of educational institutes across the United States.
Sign-up for IMAGINiT Technologies Earns Autodesk’s National Education Authorization investment picks
2013/2/6
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in the following conferences in February 2013: A live webcast of each of Infinity's presentations will be accessible on the “investors/media” section of the company's website, www.infi.com , and will be available for 30 days following each event.
Sign-up for Infinity to Participate in Three Conferences in February investment picks
2013/2/6
http://media.marketwire.com/attachments/201205/46590_INgen.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=982508&ProfileId=051205&sourceType=1 RIVERSIDE, CA --
Sign-up for Ingen Prepares to Deliver Initial $1+ Million Oxyview Order investment picks
2013/2/6
CRANBURY, N.J. , Feb.
Sign-up for Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter And Full Year 2012 Results investment picks
2013/2/6
Inspiration Biopharmaceuticals (Inspiration) and Ipsen today announced the sale of its proprietary hemophilia B product, IB1001 (recombinant FIX), to Cangene Corporation (TSX: CNJ) (Cangene). Ipsen (Euronext: IPN; ADR: IPSEY) sold its commercialization rights to IB1001 as part of the transaction.
Sign-up for Inspiration Biopharmaceuticals and Ipsen Complete Sale Process for All Hemophilia Assets investment picks
2013/2/6
International Shipholding Corporation (NYSE: ISH) today announced financial results for the quarter ended December 31, 2012.
Sign-up for International Shipholding Corporation Reports Fourth Quarter and Year-End 2012 Results investment picks
2013/2/6
NEW YORK, Feb.
Sign-up for INTL FCStone Inc. Reports Fiscal 2013 First Quarter Financial Results investment picks
2013/2/6
ATLANTA , Feb.
Sign-up for Invesco Mortgage Capital Inc. to Present at Credit Suisse Financial Services Forum investment picks
2013/2/6
iRobot Corp.
Sign-up for iRobot Reports Fourth-Quarter and Full-Year Financial Results investment picks
2013/2/6
SAN JOSE, Calif., Feb.
Sign-up for ISSI Announces Sampling of 4Gb DDR3 SDRAM investment picks
2013/2/6
Taps Closing Liquidity with Greater Precision NEW YORK , Feb.
Sign-up for ITG Launches New Dynamic Close Algorithm investment picks
2013/2/6
ITT Corporation (NYSE: ITT) today announced that Robert J.
Sign-up for ITT to Participate in Gabelli & Company’s 23rd Annual Pump, Valve and Energy Infrastructure Conference investment picks
2013/2/6
Apple® today announced that music fans have purchased and downloaded more than 25 billion songs from the iTunes Store® ( www.itunes.com ), the world’s most popular online music, TV and movie store.
Sign-up for iTunes Store Sets New Record with 25 Billion Songs Sold investment picks
2013/2/6
J.P. Morgan announced a $1.5 million grant today, made through the JPMorgan Chase Foundation, to renew its commitment to Bankers without Borders, a global volunteer program that supports economic development in the world’s most poverty stricken communities.
Sign-up for J.P. Morgan Renews Commitment to Bankers without Borders with $1.5 Million Grant investment picks
2013/2/6
Japan Advanced Institute of Science and Technology (JAIST) has selected Dell Compellent arrays to provide high-performance and large capacity storage for its growing, private cloud environment that supports its students and researchers.
Sign-up for Japan Advanced Institute of Science and Technology Selects Dell to Build Three-Petabyte Storage Infrastructure, Supporting High Performance and Capacity Needs of Institute’s Research investment picks
2013/2/6
Joe’s Jeans Inc. (Nasdaq: JOEZ) announced today that it plans to hold its Annual Meeting of Stockholders of Joe’s Jeans Inc. (the “Company”) on April 8, 2013 (the “2013 Annual Meeting”) in Los Angeles, California.
Sign-up for Joe’s Jeans Announces Date of 2013 Annual Meeting of Stockholders investment picks
2013/2/6
NEW YORK , Feb.
Sign-up for John C. Ferrara to Join TheStreet as Chief Financial Officer investment picks
2013/2/6
Alcoa (NYSE:AA) announced today that John Martin, 48, has been named President of Alcoa Global Primary Products – United States (GPP-US). In this role, Mr.
Sign-up for John Martin Named President of Alcoa Global Primary Products – United States investment picks
2013/2/6
Jovian Announces Acquisition of 100% of Leon Frazer & Associates Inc. Canada NewsWire TORONTO , Feb.
Sign-up for Jovian Announces Acquisition of 100% of Leon Frazer & Associates Inc. investment picks
2013/2/6
Kansas City Southern (KCS) (NYSE: KSU) Executive Vice President Sales and Marketing, Patrick Ottensmeyer, will address two transportation conferences in February.
Sign-up for KCS’ Patrick Ottensmeyer to Address Two Transportation Conferences in February investment picks
2013/2/6
Kemper Corporation (NYSE: KMPR) announced today that its Board of Directors has declared a quarterly dividend of $0.24 per share.
Sign-up for Kemper Announces Quarterly Dividend investment picks
2013/2/6
LATROBE, Pa.
Sign-up for Kennametal Management to Meet with Financial Community In Boston & New York City investment picks
2013/2/6
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor, LLP announce that a federal class action lawsuit has been filed against Keryx Biopharmaceuticals, Inc. (“Keryx” or “Company”) (NasdaqCM: KERX). The firms are investigating additional legal claims against the officers and Board of Directors of Keryx during the period of June 1, 2009 to April 1, 2012 (the “Class Period”). If you are an affected investor and you want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com , or Zachary Groover at Powers Taylor, LLP, toll free (877) 728-9607, via e-mail at zach@powerstaylor.com .
Sign-up for Keryx Biopharmaceuticals Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: IIROC Trade Resumption - SVB to Keryx Biopharmaceuticals Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity